Data / Form D filings / Biosceptre International Ltd
Biosceptre International Ltd: Form D filings
Biosceptre International Ltd, a biotechnology company in Cambridge, United Kingdom, filed 4 Form D notices with the SEC between 2016 and 2026. The latest, on July 28, 2026, reports $345,981 sold of a $345,981 offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- SALISBURY HOURSE STATION ROAD, Cambridge, United Kingdom, CB1 2
- Phone
- 44 1223 496 090
- Industry
- Biotechnology
- Entity type
- Other
- Incorporated in
- United Kingdom
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1675425
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | New notice | $345,981 | $345,981 | 10 | Jun 25, 2026 | sec.gov | |
| Jun 6, 2017 | New notice | $30,900,000 | $237,230 | $30,662,770 | 5 | May 22, 2017 | sec.gov |
| Aug 11, 2016 | New notice | Indefinite | $99,270 | 3 | Dec 16, 2015 | sec.gov | |
| Aug 11, 2016 | New notice | Indefinite | $671,674 | 7 | Mar 12, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Gavin Currie | Executive Officer, Director | |
| Andrew Walton Green | Director | |
| Michael Lovett | Director | |
| Colin Wood | Director |
Every Form D from the week of Jul 27, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Biosceptre International Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.